CX3CL1 and osteosarcoma: Transfecting osteosarcoma cells with PI3K and Akt dominant mutants (DN-PI3K and DN-Akt) also inhibited fractalkine-induced cell migration and ICAM-1 expression (Figure 3F-3G).